Biotech

All Articles

Novartis sparks brand new stage of Voyager deal along with $15M capsid package

.Novartis levels a brand new outpost in its partnership along with Voyager Rehabs, paying for $15 mi...

Lilly blog posts extra favorable records on its every week insulin prospect

.On the heels of an FDA being rejected for its own main rivalrous Novo Nordisk, Eli Lilly is making ...

IN 8bio stops phase 2 test, lays off half of workforce

.Simply a handful of months after application the first client in a period 2 trial for newly detecte...

Lilly, Haya ink $1B biobuck being overweight pact to browse black genome

.Eli Lilly's search for being overweight aim ats has actually led it to the dark genome. The Big Pha...

ArsenalBio increases $325M, pivots far from former lead resource

.Collection Biosciences is actually moving on up. The tissue therapy company has actually added $325...

Lilly- backed weight reduction biotech data IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' marijuana usage medication flunks stage 2b, driving Indivior to re-think $100M alternative

.Aelis Farma's hopes of protecting a simple, beneficial choice on a $100 million choice settlement h...

ProKidney halts stage 3 test certainly not needed to have for cell treatment confirmation

.ProKidney has quit some of a set of phase 3 trials for its own tissue therapy for kidney condition ...

Vaxcyte rises on 'impressive' 31-valent PCV gain versus Pfizer

.Vaxcyte revealed what experts referred to as "impressive" period 1/2 records for its own 31-valent ...

Recursion's mind condition test reveals little evidence of efficiency

.Recursion has actually discovered through a very early exam of its own tech-enabled method to drug ...